A new version of ResearchHub is available.
Try it now
X
Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Submit new version
Download
Flag content
0
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population
Oncology
Immunology
Internal Medicine
Show More
Authors
Zi‐Xun Yan
,
Dehui Zou
Wenbin Qian
,
Ying Lu
,
Yuhua Li
,
Dongmei Ji
,
Xiaojian Zhu
,
Heng Mei
,
Pu Li
,
Changju Qu
,
Shouxin Zhang
,
Keshu Zhou
,
Hongmei Jing
,
Ting Niu
,
Chunyan Ji
,
Lanfang Li
,
Hua Yang
,
Fei Li
,
Wei Wang
,
Kailin Xu
,
Jinghua Zhao
,
Depei Wu
,
Yu Hu
,
Weili Zhao
,
Lei Zhang
+23 authors
,
Qian Zhang
Journal
Blood
Published
Nov 5, 2024
DOI
10.1182/blood-2024-207186
Show more
Save
Tip
Document
Submit new version
Download
Flag content
0
Tip
Save
Document
Submit new version
Download
Flag content
Paper
Conversation
Grants
Reviews
Post
Best
Best
Newest
Upvoted
Start the discussion.
This paper has not yet been discussed.